Company / Current Liabilities per Share
C4 Therapeutics, Inc. Current Liabilities per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.47
FY2025
5-year range
$0.47 / $0.91
FY2022-FY2025
Trend
-37.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share has declined for 3 consecutive years, from $0.91 in FY2022 to $0.47 in FY2025.
Based on SEC 10-K filings.
0.47 in FY2025 with a 3-year CAGR of -20.0%.
Improved from $0.87 to $0.47 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -20.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- C4 Therapeutics, Inc.'s current liabilities per share has declined for 3 consecutive years.
- In FY2025, current liabilities per share decreased 37.4% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.47 | -37.4% |
| FY2024 | $0.75 | -14.5% |
| FY2023 | $0.87 | -4.5% |
| FY2022 | $0.91 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026